Effect	O
of	O
New	O
-	O
Onset	O
Left	B:C0023211
Bundle	I:C0023211
Branch	I:C0023211
Block	I:C0023211
After	O
Transcatheter	O
Aortic	I:C3509486
Valve	I:C3509486
Implantation	I:C3509486
(	O
CoreValve	O
)	O
on	O
Mortality	O
,	O
Frequency	O
of	O
Re-Hospitalization	O
,	O
and	O
Need	O
for	O
Pacemaker	O
.	O

Effect	O
of	O
New	O
-	O
Onset	O
Left	O
Bundle	I:C0023211
Branch	I:C0023211
Block	I:C0023211
After	O
Transcatheter	B:C3509486
Aortic	I:C3509486
Valve	I:C3509486
Implantation	I:C3509486
(	O
CoreValve	O
)	O
on	O
Mortality	O
,	O
Frequency	O
of	O
Re-Hospitalization	O
,	O
and	O
Need	O
for	O
Pacemaker	O
.	O

Effect	O
of	O
New	O
-	O
Onset	O
Left	O
Bundle	I:C0023211
Branch	I:C0023211
Block	I:C0023211
After	O
Transcatheter	O
Aortic	I:C3509486
Valve	I:C3509486
Implantation	I:C3509486
(	O
CoreValve	B:C0184252
)	O
on	O
Mortality	O
,	O
Frequency	O
of	O
Re-Hospitalization	O
,	O
and	O
Need	O
for	O
Pacemaker	O
.	O

Effect	O
of	O
New	O
-	O
Onset	O
Left	O
Bundle	I:C0023211
Branch	I:C0023211
Block	I:C0023211
After	O
Transcatheter	O
Aortic	I:C3509486
Valve	I:C3509486
Implantation	I:C3509486
(	O
CoreValve	O
)	O
on	O
Mortality	O
,	O
Frequency	O
of	O
Re-Hospitalization	B:C0019993
,	O
and	O
Need	O
for	O
Pacemaker	O
.	O

Effect	O
of	O
New	O
-	O
Onset	O
Left	O
Bundle	I:C0023211
Branch	I:C0023211
Block	I:C0023211
After	O
Transcatheter	O
Aortic	I:C3509486
Valve	I:C3509486
Implantation	I:C3509486
(	O
CoreValve	O
)	O
on	O
Mortality	O
,	O
Frequency	O
of	O
Re-Hospitalization	O
,	O
and	O
Need	O
for	O
Pacemaker	B:C0030163
.	O

New	O
-	O
onset	O
conduction	B:C0232219
disturbances	I:C0232219
are	O
common	O
after	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
(	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
)	O
.	O

New	O
-	O
onset	O
conduction	O
disturbances	I:C0232219
are	O
common	O
after	O
transcatheter	B:C3509486
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
(	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
)	O
.	O

New	O
-	O
onset	O
conduction	O
disturbances	I:C0232219
are	O
common	O
after	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
(	O
transcatheter	B:C3509486
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
)	O
.	O

The	O
most	O
common	O
complication	B:C0009566
is	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
(	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
)	O
.	O

The	O
most	O
common	O
complication	O
is	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
(	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
)	O
.	O

The	O
most	O
common	O
complication	O
is	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
(	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
)	O
.	O

The	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
after	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
remains	O
controversial	O
.	O

The	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
after	O
transcatheter	B:C3509486
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
remains	O
controversial	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemakers	O
and	O
admissions	O
for	O
heart	O
failure	I:C0018801
)	O
at	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemakers	B:C0030163
and	O
admissions	O
for	O
heart	O
failure	I:C0018801
)	O
at	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemakers	O
and	O
admissions	B:C0030673
for	O
heart	O
failure	I:C0018801
)	O
at	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemakers	O
and	O
admissions	O
for	O
heart	B:C0018801
failure	I:C0018801
)	O
at	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
the	O
clinical	O
impact	O
of	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
in	O
terms	O
of	O
mortality	O
and	O
morbidity	O
(	O
need	O
for	O
pacemakers	O
and	O
admissions	O
for	O
heart	O
failure	I:C0018801
)	O
at	O
long	B:C1517942
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

From	O
April	O
2008	O
to	O
December	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	B:C0003507
stenosis	I:C0003507
were	O
treated	O
with	I:C0332293
the	O
implantation	O
of	O
a	O
CoreValve	O
prosthesis	I:C0184252
.	O

From	O
April	O
2008	O
to	O
December	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	O
stenosis	I:C0003507
were	O
treated	B:C0332293
with	I:C0332293
the	O
implantation	O
of	O
a	O
CoreValve	O
prosthesis	I:C0184252
.	O

From	O
April	O
2008	O
to	O
December	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	O
stenosis	I:C0003507
were	O
treated	O
with	I:C0332293
the	O
implantation	B:C0021107
of	O
a	O
CoreValve	O
prosthesis	I:C0184252
.	O

From	O
April	O
2008	O
to	O
December	O
2014	O
,	O
220	O
patients	O
who	O
had	O
severe	O
aortic	O
stenosis	I:C0003507
were	O
treated	O
with	I:C0332293
the	O
implantation	O
of	O
a	O
CoreValve	B:C0184252
prosthesis	I:C0184252
.	O

Sixty	O
-	O
seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	B:C0936012
,	O
including	O
22	O
patients	O
with	O
pre-existing	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	O
previously	O
or	O
within	O
72	O
hours	O
of	O
implantation	O
.	O

Sixty	O
-	O
seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	O
,	O
including	O
22	O
patients	O
with	O
pre-existing	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	O
previously	O
or	O
within	O
72	O
hours	O
of	O
implantation	O
.	O

Sixty	O
-	O
seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	O
,	O
including	O
22	O
patients	O
with	O
pre-existing	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	B:C0021102
previously	O
or	O
within	O
72	O
hours	O
of	O
implantation	O
.	O

Sixty	O
-	O
seven	O
of	O
these	O
patients	O
were	O
excluded	O
from	O
the	O
analysis	O
,	O
including	O
22	O
patients	O
with	O
pre-existing	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
and	O
45	O
with	O
a	O
permanent	O
pacemaker	O
,	O
implanted	O
previously	O
or	O
within	O
72	O
hours	O
of	O
implantation	B:C0021107
.	O

The	O
remaining	O
153	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
1	O
(	O
n	O
=	O
80	O
)	O
,	O
those	O
with	O
persistent	O
new	O
-	O
onset	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
,	O
and	O
group	O
2	O
(	O
n	O
=	O
73	O
)	O
,	O
those	O
without	O
conduction	O
disturbances	I:C0232219
after	O
treatment	O
.	O

The	O
remaining	O
153	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
1	O
(	O
n	O
=	O
80	O
)	O
,	O
those	O
with	O
persistent	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
,	O
and	O
group	O
2	O
(	O
n	O
=	O
73	O
)	O
,	O
those	O
without	O
conduction	B:C0232219
disturbances	I:C0232219
after	O
treatment	O
.	O

The	O
remaining	O
153	O
patients	O
were	O
divided	O
into	O
2	O
groups	O
:	O
group	O
1	O
(	O
n	O
=	O
80	O
)	O
,	O
those	O
with	O
persistent	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
,	O
and	O
group	O
2	O
(	O
n	O
=	O
73	O
)	O
,	O
those	O
without	O
conduction	O
disturbances	I:C0232219
after	O
treatment	B:C0087111
.	O

Both	O
groups	O
were	O
followed	B:C1522577
up	I:C1522577
at	O
1	O
month	O
,	O
6	O
months	O
,	O
12	O
months	O
,	O
and	O
yearly	O
thereafter	O
.	O

Persistent	O
new	O
-	O
onset	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
occurred	O
in	O
80	O
patients	O
(	O
36	O
%	O
)	O
immediately	O
after	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
;	O
73	O
patients	O
(	O
33	O
%	O
)	O
did	O
not	O
develop	O
conduction	O
disturbances	I:C0232219
.	O

Persistent	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
occurred	O
in	O
80	O
patients	O
(	O
36	O
%	O
)	O
immediately	O
after	O
transcatheter	B:C3509486
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
;	O
73	O
patients	O
(	O
33	O
%	O
)	O
did	O
not	O
develop	O
conduction	O
disturbances	I:C0232219
.	O

Persistent	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
occurred	O
in	O
80	O
patients	O
(	O
36	O
%	O
)	O
immediately	O
after	O
transcatheter	O
aortic	I:C3509486
valve	I:C3509486
implantation	I:C3509486
;	O
73	O
patients	O
(	O
33	O
%	O
)	O
did	O
not	O
develop	O
conduction	B:C0232219
disturbances	I:C0232219
.	O

The	O
mean	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
time	O
of	O
both	O
groups	O
was	O
32	O
Â±	O
22	O
months	O
(	O
range	O
3	O
to	O
82	O
months	O
)	O
,	O
and	O
there	O
were	O
no	O
differences	O
in	O
time	O
between	O
the	O
groups	O
.	O

No	O
differences	O
were	O
observed	O
between	O
the	O
groups	O
in	O
re-hospitalizations	B:C0019993
for	O
heart	O
failure	I:C0018801
(	O
11	O
%	O
vs	O
16	O
%	O
,	O
p	O
=	O
0.55	O
)	O
.	O

No	O
differences	O
were	O
observed	O
between	O
the	O
groups	O
in	O
re-hospitalizations	O
for	O
heart	B:C0018801
failure	I:C0018801
(	O
11	O
%	O
vs	O
16	O
%	O
,	O
p	O
=	O
0.55	O
)	O
.	O

Group	O
1	O
did	O
not	O
require	O
pacemaker	B:C0189842
implantation	I:C0189842
more	O
often	O
at	O
follow	O
-	I:C1522577
up	I:C1522577
(	O
10	O
%	O
vs	O
13	O
%	O
,	O
p	O
=	O
0.38	O
)	O
than	O
group	O
2	O
.	O

Group	O
1	O
did	O
not	O
require	O
pacemaker	O
implantation	I:C0189842
more	O
often	O
at	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
(	O
10	O
%	O
vs	O
13	O
%	O
,	O
p	O
=	O
0.38	O
)	O
than	O
group	O
2	O
.	O

In	O
conclusion	O
,	O
new	O
-	O
onset	O
left	B:C0023211
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
was	O
not	O
associated	O
with	O
a	O
higher	O
incidence	O
of	O
late	O
need	O
for	O
a	O
permanent	O
pacemaker	O
after	O
CoreValve	O
implantation	O
.	O

In	O
conclusion	O
,	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
was	O
not	O
associated	O
with	O
a	O
higher	O
incidence	O
of	O
late	O
need	O
for	O
a	O
permanent	O
pacemaker	O
after	O
CoreValve	B:C0184252
implantation	O
.	O

In	O
conclusion	O
,	O
new	O
-	O
onset	O
left	O
bundle	I:C0023211
branch	I:C0023211
block	I:C0023211
was	O
not	O
associated	O
with	O
a	O
higher	O
incidence	O
of	O
late	O
need	O
for	O
a	O
permanent	O
pacemaker	O
after	O
CoreValve	O
implantation	B:C0021107
.	O

In	O
addition	O
,	O
it	O
was	O
not	O
associated	O
with	O
a	O
higher	O
risk	O
of	O
late	O
mortality	O
or	O
re-hospitalization	B:C0019993
.	O

